cepharanthine has been researched along with interleukin-8 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ebina, T; Murata, K | 1 |
Azuma, M; Bando, T; Kawashima, Y; Motegi, K; Takamaru, N; Tamatani, T | 1 |
Ferdous, T; Harada, K; Itashiki, Y; Mano, T; Mori, Y; Takii, M; Ueyama, Y | 1 |
3 other study(ies) available for cepharanthine and interleukin-8
Article | Year |
---|---|
[Antitumor Effector mechanism of plant alkaloid preparation, cepharanthin, by intratumoral administration].
Topics: Alkaloids; Animals; Antineoplastic Agents; Benzylisoquinolines; Chemotactic Factors; Injections, Intralesional; Interleukin-8; Lymph Node Excision; Macrophages; Mice; Mice, Inbred BALB C; Sarcoma, Experimental | 1991 |
Cepharanthin-enhanced radiosensitivity through the inhibition of radiation-induced nuclear factor-kappaB activity in human oral squamous cell carcinoma cells.
Topics: Alkaloids; Animals; Apoptosis; Benzylisoquinolines; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Fluorescent Antibody Technique; Gamma Rays; Humans; I-kappa B Kinase; Inhibitor of Apoptosis Proteins; Interleukin-6; Interleukin-8; Luciferases; Mice; Mice, Inbred BALB C; Mice, Nude; Mouth Neoplasms; NF-kappa B; Radiation-Protective Agents; Radiation, Ionizing; RNA, Messenger | 2007 |
Cepharanthine inhibits angiogenesis and tumorigenicity of human oral squamous cell carcinoma cells by suppressing expression of vascular endothelial growth factor and interleukin-8.
Topics: Animals; Antineoplastic Agents, Phytogenic; Benzylisoquinolines; Blotting, Western; Carcinoma, Squamous Cell; Cell Movement; Cell Proliferation; Cells, Cultured; Enzyme-Linked Immunosorbent Assay; Female; Humans; Immunohistochemistry; Interleukin-8; Mice; Mice, Nude; Mouth Neoplasms; Neovascularization, Pathologic; NF-kappa B; Reverse Transcriptase Polymerase Chain Reaction; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2009 |